Skip to content
Home/Companies/Pharma/Sobrera Pharma

Sobrera Pharma

Pharma·Sweden·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Sobrera Pharma?

Sobrera Pharma is a Swedish Pharma company, currently owned by GU Ventures since 2019.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
GU Ventures
Investor
GU Ventures
GU Ventures Evergreen · 1995 · VC

Key facts

HQSweden
SectorPharma
StatusActive

More from GU Ventures Evergreen

Other portfolio companies in the same fund.

Mucolife Therapeutics
Active
BiotechSweden· 2024
Pretzel Therapeutics
Pretzel Therapeutics
Active
BiotechUS· 2022
dpella
Active
Data & AnalyticsSweden· 2021
Nanolyze
Active
Deep TechSweden· 2020
SimSen Diagnostics
Active
MedTechSweden· 2020
Hydroc Energy Storage
Active
ClimateTechSweden· 2019

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Sobrera Pharma?

Sobrera Pharma is currently owned by GU Ventures, through GU Ventures Evergreen, since 2019.

When did GU Ventures acquire Sobrera Pharma?

GU Ventures acquired Sobrera Pharma in 2019.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue